GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (MEX:INO) » Definitions » Total Liabilities

Inovio Pharmaceuticals (MEX:INO) Total Liabilities : MXN932.10 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inovio Pharmaceuticals Total Liabilities?

Inovio Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2024 was MXN932.10 Mil.

Inovio Pharmaceuticals's quarterly Total Liabilities declined from Jun. 2024 (MXN678.91 Mil) to Sep. 2024 (MXN660.00 Mil) but then increased from Sep. 2024 (MXN660.00 Mil) to Dec. 2024 (MXN932.10 Mil).

Inovio Pharmaceuticals's annual Total Liabilities declined from Dec. 2022 (MXN2,459.83 Mil) to Dec. 2023 (MXN909.85 Mil) but then increased from Dec. 2023 (MXN909.85 Mil) to Dec. 2024 (MXN932.10 Mil).


Inovio Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Inovio Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Total Liabilities Chart

Inovio Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,564.15 1,974.92 2,459.83 909.85 932.10

Inovio Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 909.85 575.43 678.91 660.00 932.10

Inovio Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inovio Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=736.748+(195.376+-0.02000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=932.10

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=2360.803-1428.699
=932.10

Inovio Pharmaceuticals's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=736.748+(195.376+-0.02000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=932.10

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=2360.803-1428.699
=932.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inovio Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Inovio Pharmaceuticals Business Description

Traded in Other Exchanges
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.